Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT05117242
Title	Safety and Efficacy Study of GEN1046 as a Single Agent or in Combination With Pembrolizumab for Treatment of Recurrent (Non-small Cell) Lung Cancer
Recruitment	Active, not recruiting
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	Genmab
Indications	lung non-small cell carcinoma
Therapies	GEN1046 + Pembrolizumab GEN1046
Age Groups:	adult \| senior
Covered Countries	USA \| POL \| NLD \| ITA \| GBR \| FRA \| ESP \| DEU